Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study

Elise M van Praag, Merel E Stellingwerf, Jarmila D W van der Bilt, Wilhelmus A Bemelman, Krisztina B Gecse, Christianne J Buskens, Elise M van Praag, Merel E Stellingwerf, Jarmila D W van der Bilt, Wilhelmus A Bemelman, Krisztina B Gecse, Christianne J Buskens

Abstract

Background and aims: Ligation of the intersphincteric fistula tract [LIFT] and advancement flap [AF] procedures are well-established, sphincter-preserving procedures for closure of high perianal fistulas. As surgical fistula closure is not commonly offered in Crohn's disease patients, long-term data are limited. This study aims to evaluate outcomes after LIFT and AF in Crohn's high perianal fistulas.

Methods: All consecutive Crohn's disease patients ≥18 years old treated with LIFT or AF between January 2007 and February 2018 were included. The primary outcome was clinical healing and secondary outcomes included radiological healing, recurrence, postoperative incontinence and Vaizey Incontinence Score.

Results: Forty procedures in 37 patients [LIFT: 19, AF: 21, 35.1% male] were included. A non-significant trend was seen towards higher clinical healing percentages after LIFT compared to AF [89.5% vs 60.0%; p = 0.065]. Overall radiological healing rates were lower for both approaches [LIFT 52.6% and AF 47.6%]. Recurrence rates were comparable: 21.1% and 19.0%, respectively. In AF a trend was seen towards higher clinical healing percentages when treated with anti-tumour necrosis factor/immunomodulators [75.0% vs 37.5%; p = 0.104]. Newly developed postoperative incontinence occurred in 15.8% after LIFT and 21.4% after AF. Interestingly, 47.4% of patients had a postoperatively improved Vaizey Score [LIFT: 52.9% and AF: 42.9%]. The mean Vaizey Score decreased from 6.8 [SD 4.8] preoperatively to 5.3 [SD 5.0] postoperatively [p = 0.067].

Conclusions: Both LIFT and AF resulted in satisfactory closure rates in Crohn's high perianal fistulas. However, a discrepancy between clinical and radiological healing rates was found. Furthermore, almost half of the patients benefitted from surgical intervention with respect to continence.

Keywords: Crohn’s disease; Perianal fistula; surgery.

© European Crohn’s and Colitis Organisation (ECCO) 2019.

Figures

Figure 1.
Figure 1.
Kaplan–Meier plot of recurrence-free survival after LIFT [n = 19] and AF [n = 21]. LIFT, ligation of the intersphincteric fistula tract; AF, advancement flap.

References

    1. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. .. The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875–80.
    1. European Crohn’s and Colitis Organisation. ECCO Crohn’s Disease (CD) Consensus Update (2016)2001. [Available from: .
    1. Lee MJ, Parker CE, Taylor SR, et al. . Efficacy of medical therapies for fistulizing crohn’s disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:1879–92.
    1. Strik A, Löwenberg M, Ponsioen C, et al. . Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn’s disease patients. Scand J Gastroenterol 2019;54:453–8.
    1. Cornillie F, Hanauer SB, Diamond RH, et al. .. Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial. Gut 2014;63:1721–7.
    1. Yarur AJ, Kanagala V, Stein DJ, et al. .. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn’s disease. Aliment Pharmacol Ther 2017;45:933–40.
    1. Crowell KT, Tinsley A, Williams ED, et al. .. Vedolizumab as a rescue therapy for patients with medically refractory Crohn’s disease. Colorectal Dis 2018;20:905–12.
    1. Christoforidis D, Pieh MC, Madoff RD, Mellgren AF. Treatment of transsphincteric anal fistulas by endorectal advancement flap or collagen fistula plug: a comparative study. Dis Colon Rectum 2009;52: 18–22.
    1. van Praag EM, Buskens CJ. The LIFT procedure for a perianal Crohn’s fistula—a video vignette. Colorectal Dis 2019;21:853–4.
    1. Buchanan GN, Halligan S, Bartram CI, Williams AB, Tarroni D, Cohen CR. Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: comparison with outcome-based reference standard. Radiology 2004;233:674–81.
    1. Stellingwerf ME, van Praag EM, Tozer PJ, Bemelman WA, Buskens CJ. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn’s high perianal fistulas. BJS Open 2019;3:231–41.
    1. Kamiński JP, Zaghiyan K, Fleshner P. Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn’s disease: what have we learned? Colorectal Dis 2017;19:750–5.
    1. Vaizey CJ, Carapeti E, Cahill JA, Kamm MA. Prospective comparison of faecal incontinence grading systems. Gut 1999;44:77–80.
    1. Rojanasakul A. LIFT procedure: a simplified technique for fistula-in-ano. Tech Coloproctol 2009;13:237–40.
    1. Shanwani A, Nor AM, Amri N. Ligation of the intersphincteric fistula tract (LIFT): a sphincter-saving technique for fistula-in-ano. Dis Colon Rectum 2010;53:39–42.
    1. Aboulian A, Kaji AH, Kumar RR. Early result of ligation of the intersphincteric fistula tract for fistula-in-ano. Dis Colon Rectum 2011;54:289–92.
    1. Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976;63:1–12.
    1. van Koperen PJ, Wind J, Bemelman WA, Bakx R, Reitsma JB, Slors JF. Long-term functional outcome and risk factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin. Dis Colon Rectum 2008;51:1475–81.
    1. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007;7:541–6.
    1. Strik AS, Bots SJ, D’Haens G, Löwenberg M. Optimization of anti-TNF therapy in patients with inflammatory bowel disease. Expert Rev Clin Pharmacol 2016;9:429–39.
    1. Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn’s fistula-in-ano. Dis Colon Rectum 2010;53:486–95.
    1. de Groof EJ, Buskens CJ, Ponsioen CY, et al. .. Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial. Trials 2015;16:366.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다